| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |